212 filings
8-K
CLOV
Clover Health Investments Corp - Ordinary Shares
7 May 24
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability
4:07pm
ARS
2024 FY
CLOV
Clover Health Investments Corp - Ordinary Shares
26 Apr 24
Annual report to shareholders
4:08pm
DEFA14A
CLOV
Clover Health Investments Corp - Ordinary Shares
26 Apr 24
Additional proxy soliciting materials
4:07pm
8-K
gt8sz3orc9sg6vo9t3u
22 Apr 24
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
4:06pm
8-K
tnavlo0yy580x3
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
m35eysy68ls360yh
4 Apr 24
Other Events
4:33pm
S-8
9l9ntngh3k01 fli4
28 Mar 24
Registration of securities for employees
4:06pm
8-K
4tagbgkc9
12 Mar 24
Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year
4:07pm
8-K
ellichys7 9x9qrqxc
10 Jan 24
Clover Health Provides Business Update and Full-Year 2024 Objectives
8:31am
8-K
d91dyiatp th
27 Dec 23
Departure of Directors or Certain Officers
8:05am
8-K
ditwtgl37tbabqy
21 Dec 23
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
8:02am
8-K
hnkmmy3rh
1 Dec 23
Cost Associated with Exit or Disposal Activities
8:16am
8-K
h6ocw6k r95hut
6 Nov 23
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
4:07pm
8-K
vaahdfniq51udb62xed
3 Nov 23
Departure of Directors or Certain Officers
4:16pm
DEFA14A
3i8h59za
28 Aug 23
Additional proxy soliciting materials
4:06pm
8-K
p2g9t 1b90awjk
28 Aug 23
Other Events
4:05pm